LYC Healthcare Berhad - Income Statement (TTM)

LYC Healthcare Berhad
MY ˙ KLSE
Income Statement (TTM)

LYC Healthcare Berhad Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.

All numbers are times 1,000,000 except per share units.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 13 16 26 35 44 58 65 74 84 86 92 98 108 121 129 142 152 157 156 148
Change (%) 22.19 63.78 34.36 23.31 33.49 10.58 14.58 13.32 2.78 7.05 5.97 10.63 11.49 6.94 9.88 7.43 3.06 -0.90 -4.70
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 10 11 15 18 21 28 32 39 46 47 51 52 54 57 61 66 71 73 87 84
Change (%) 9.57 31.44 19.41 16.50 36.53 15.36 19.11 18.78 3.00 7.36 2.99 2.55 6.35 6.63 8.68 8.13 2.18 18.70 -3.34
% of Revenue 77.82 69.78 56.00 49.77 47.02 48.09 50.17 52.15 54.67 54.78 54.94 53.39 49.49 47.21 47.08 46.56 46.86 46.46 55.65 56.44
Gross Operating Profit 3 5 12 18 23 30 32 35 38 39 42 46 55 64 68 76 81 84 69 65
Change (%) 66.46 138.45 53.38 30.05 30.79 6.16 10.01 7.37 2.51 6.68 9.61 19.89 16.53 7.22 10.95 6.82 3.83 -17.91 -6.40
% of Revenue 22.18 30.22 44.00 50.23 52.98 51.91 49.83 47.85 45.33 45.22 45.06 46.61 50.51 52.79 52.92 53.44 53.14 53.54 44.35 43.56
SG&A 14 18 19 23 26 29 32 34 35 35 40 44 55 66 76 83 83 82 69 66
Change (%) 28.46 2.57 20.27 13.26 12.85 11.33 5.25 4.53 -1.53 15.21 10.30 23.13 20.51 15.54 9.24 -0.12 -0.96 -16.05 -3.93
% of Revenue 108.10 113.65 71.18 63.71 58.52 49.48 49.81 45.76 42.21 40.44 43.52 45.30 50.42 54.50 58.88 58.53 54.42 52.30 44.30 44.66
R&D
Change (%)
% of Revenue
OpEx 24 27 32 38 44 54 57 65 75 77 91 94 105 118 131 145 150 153 151 145
Change (%) 16.30 16.31 20.93 13.84 23.30 5.51 14.47 14.35 3.25 17.84 4.04 11.16 12.19 11.01 10.83 3.61 1.68 -0.83 -4.05
% of Revenue 178.11 169.52 120.39 108.36 100.05 92.41 88.17 88.09 88.89 89.30 98.30 96.51 96.97 97.58 101.29 102.17 98.53 97.21 97.27 97.93
Operating Income -10 -11 -5 -3 -0 4 8 9 9 9 2 3 3 3 -2 -3 2 4 4 3
Change (%) 8.76 -51.96 -44.89 -99.27 -20,622.28 72.35 15.36 5.72 -1.01 -83.01 117.90 -4.10 -11.00 -157.29 83.88 -173.01 95.50 -3.17 -27.58
% of Revenue -78.11 -69.52 -20.39 -8.36 -0.05 7.59 11.83 11.91 11.11 10.70 1.70 3.49 3.03 2.42 -1.29 -2.17 1.47 2.79 2.73 2.07
Interest Expense -1 -3 -4 -5 -7 -8 -9 -10 -11 -11 -11 -11 -10 -10 -9 -10 -10 -11 -11 -11
Change (%) 87.98 51.59 34.26 25.99 18.78 10.15 10.97 10.42 0.66 3.87 -2.55 -4.39 -5.81 -3.83 0.79 1.01 16.13 -4.38 4.98
% of Revenue -10.52 -16.19 -14.98 -14.97 -15.30 -13.61 -13.56 -13.13 -12.80 -12.53 -12.16 -11.18 -9.66 -8.16 -7.34 -6.73 -6.33 -7.14 -6.88 -7.58
Net Income -12 -14 -12 -12 -12 -11 -9 -11 -12 -12 -19 -17 -17 -17 -21 -22 -19 -18 -17 -18
Change (%) 20.63 -15.22 3.79 0.93 -8.95 -18.47 15.66 13.42 2.31 54.95 -11.86 -0.98 1.19 22.62 5.90 -14.06 -6.95 -3.00 6.56
% of Revenue -87.90 -86.77 -44.92 -34.70 -28.40 -19.37 -14.28 -14.42 -14.43 -14.36 -20.79 -17.29 -15.48 -14.05 -16.11 -15.53 -12.42 -11.21 -10.97 -12.27

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista